Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 4431-4439, December 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramanath Rao, B.
Right arrow Articles by Heston, W. D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramanath Rao, B.
Right arrow Articles by Heston, W. D. W.

Establishment and Characterization of an in Vitro Clonogenic Cell Assay for the R-3327-At Copenhagen Rat Prostatic Tumor1

B. Ramanath Rao, Alexander Nakeff, Charles Eaton and Warren D. W. Heston

Section of Cancer Biology, Division of Radiation Oncology, Mallinckrodt Institute of Radiology [B. R. R., A. N., C. E.], and Division of Urology, Department of Surgery [W. D. W. H.], Washington University School of Medicine, St. Louis, Missouri 63110

We have established an in vitro clonogenic cell assay for a class of anaplastic rat prostatic tumor cells (R-3327-At). We used collagenase to isolate these cells from transplanted solid tumors growing in the flanks of mature male Copenhagen rats and cultured them in {alpha}-minimal essential medium supplemented with 10% fetal calf serum. A linear relationship was obtained between the number of cells plated and the number of colonies formed. R-3327-At clonogenic cells had a plating efficiency of about 4% when monodispersed cells were isolated from the primary tumor, and their cell doubling time was 24 hr. Cultured tumor cells have maintained their ability to induce tumors when retransplanted into normal male reciplent rats even after 30 weekly passages in vitro, although later passages were not as "tumorigenic." The R-3327-At cells were readily distinguishable from fibroblasts on the basis of cellular morphology and growth kinetics and because only the R-3327-At cells were able to proliferate in semisolid (plasma) culture and induce tumors upon retransplantation in vivo.

The addition of conditioned media (CM) prepared from R-3327-At tumor cell cultures to low density R-3327-At cell cultures produced larger colonies compared to those cultures to which we added either no CM or CM from Copenhagen rat skin fibroblasts. These data indicated that the growth-promoting activity present in the CM of R-3327-At cultures can increase the extent of proliferation, although it is not essential for its initiation. The addition of sera from rats bearing either the R-3327-At or the hormone-dependent (R-3327-H) tumor was "cytotoxic" to R-3327-At clonogenic cells. Not only were fewer colonies formed, but also individual colonies contained fewer cells when compared to control cultures to which normal rat serum was added. These findings are potentially important since they may reflect a host immune response to the tumor.

1 This investigation was supported by Grant 5PO1CA13053-05 and awarded by the National Cancer Institute, Department of Health, Education, and Welfare.

Received 3/27/78. Accepted 8/31/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.